Cargando…
Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is a rare but aggressive tumor that originates in the pleura, is diagnosed in advanced stages and has a poor prognosis. Accurate diagnosis of MPM is often difficult and complex, and the gold standard diagnosis test is based on qualitative analysis of markers in p...
Autores principales: | Martínez-Rivera, Vanessa, Negrete-García, María Cristina, Ávila-Moreno, Federico, Ortiz-Quintero, Blanca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855817/ https://www.ncbi.nlm.nih.gov/pubmed/29462963 http://dx.doi.org/10.3390/ijms19020595 |
Ejemplares similares
-
Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma
por: Gayosso-Gómez, LV, et al.
Publicado: (2014) -
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
por: De Santi, Chiara, et al.
Publicado: (2017) -
Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy
por: Tomasetti, Marco, et al.
Publicado: (2019) -
Serum Expression Levels of Certain miRNAs in Predicting Diagnosis, Prognosis, and Response to Chemotherapy in Malignant Pleural Mesothelioma
por: Metintaş, Muzaffer, et al.
Publicado: (2022) -
Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)